Armata Pharmaceuticals (ARMP) Net Equity Issued and Repurchased (2016 - 2022)
Armata Pharmaceuticals (ARMP) reported Net Equity Issued and Repurchased of -$23000.0 for Q3 2022, up 89.4% sequentially from -$217000.0 in Q2 2022.
Armata Pharmaceuticals (ARMP) Net Equity Issued and Repurchased (2016 - 2022) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 4 years of Net Equity Issued and Repurchased data on file, last reported at -$23000.0 in Q3 2022.
- For the quarter ending Q3 2022, Net Equity Issued and Repurchased changed N/A year-over-year to -$23000.0; the trailing twelve-month figure through Dec 2022 stood at $44.4 million (up 68.67% YoY), and the FY2022 full-year result was $44.4 million, up 68.67% from the prior year.
- Net Equity Issued and Repurchased rose to -$23000.0 in Q3 2022, from -$217000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $44.6 million in Q1 2022 to a low of -$412000.0 in Q2 2020.
- A 3-year average of $10.4 million and a median of -$23000.0 in 2022 frame the typical range for Net Equity Issued and Repurchased.
- Peak annual rise in Net Equity Issued and Repurchased reached 128.31% in 2022, while the deepest fall reached 17.3% in 2022.
- Tracing ARMP's Net Equity Issued and Repurchased over 3 years: stood at -$26000.0 in 2020, then soared by 26853.85% to $7.0 million in 2021, then plunged by 100.33% to -$23000.0 in 2022.
- Business Quant data shows ARMP's Net Equity Issued and Repurchased at -$23000.0 in Q3 2022, -$217000.0 in Q2 2022, and $44.6 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -23,000.00 |
| Sep 30, 2022 | -23,000.00 |
| Jun 30, 2022 | -217,000.00 |
| Jun 30, 2022 | -217,000.00 |
| Mar 31, 2022 | 44.63 Mn |
| Mar 31, 2022 | 44.63 Mn |
| Dec 31, 2021 | 6.96 Mn |
| Dec 31, 2021 | 6.96 Mn |
| Jun 30, 2021 | -185,000.00 |
| Jun 30, 2021 | -185,000.00 |
| Mar 31, 2021 | 19.55 Mn |
| Mar 31, 2021 | 19.55 Mn |
| Sep 30, 2020 | -26,000.00 |
| Sep 30, 2020 | -26,000.00 |
| Jun 30, 2020 | -412,000.00 |
| Jun 30, 2020 | -412,000.00 |
| Mar 31, 2020 | 23.33 Mn |
| Mar 31, 2020 | 23.33 Mn |
| Dec 31, 2016 | 3.34 Mn |
| Dec 31, 2016 | 3.34 Mn |